Global Electronic Clinical Outcome Assessment (eCOA) Market is Expected to Grow at 15.5% in the Forecast Period of 2020 to 2027

Global Electronic Clinical Outcome Assessment (eCOA) Market is growing with factors such as growing demand for eCOA solutions among clinical research professionals over traditional alternatives. eCOA solutions have shown significant improvement in data quality by increasing patient protocol compliance, prevention of conflicting or inconsistency of data, eliminating the need for transcriptions and the errors associated with the same.

Electronic clinical outcome assessment (eCOA) market has shown an exceptional penetration in countries such as U.S., U.K. and China. Growing usage of eCOA solutions is increasing the penetration in developed countries. In developing countries, rising concern related to structured data collection in clinical trials is creating opportunity for the global electronic clinical outcome assessment (eCOA) market.

Electronic Clinical Outcome Assessment (eCOA) Market Scenario

According to Data Bridge Market Research the market for electronic clinical outcome assessment (eCOA) in North America region has the highest market share followed by Europe and Asia Pacific. Market leader is Oracle which accounts an estimated market share of approximately 15% to 20% in the North America. The company has gained outstanding sale through varied product portfolio and noteworthy geographical presence.

• In February 2020, Oracle launched the cloud system solutions across five regions namely Australia (Melbourne), Japan (Osaka), Saudi Arabia (Jeddah), The Netherlands (Amsterdam) and Canada (Montreal). This market expansion shows the increasing demand for cloud-based solutions across the globe. The move is expected to attract the end users towards the product in order it will generate more revenue in the particular business segment.

Now the question is which other regions Oracle, Parexel International Corporation, ERT Clinical and Bioclinica are targeting? Data Bridge Market Research has forecasted a large growth in North-America electronic clinical outcome assessment (eCOA) market and the market leaders are targeting U.S. and Canada to be their next revenue pockets for 2020.

The electronic clinical outcome assessment (eCOA) market is becoming more competitive every year with companies such as Oracle, Parexel International Corporation, ERT Clinical and Bioclinica as they are the market leaders for electronic clinical outcome assessment (eCOA). The data bridge market research new reports highlight the major growth factors and opportunities in the electronic clinical outcome assessment (eCOA) market.

For more analysis on the electronic clinical outcome assessment (eCOA) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-electronic-clinical-outcome-assessment-ecoa-market

Electronic Clinical Outcome Assessment (eCOA) Market Development

• In October 2019, Parexel International Corporation announced its partnership with Datavant focusing on providing the assembly of real-world data through all clinical trials conducted by Parexel International Corporation.  Technology from Datavant added the connectivity to form an integrated solution. The partnership helped Parexel International Corporation to expand the product portfolio as well as market size of the company.

Scope of the Electronic Clinical Outcome Assessment (eCOA) Market

Global electronic clinical outcome assessment (eCOA) market is segmented on the basis of countries into the U.S., Canada and Mexico, Germany, U.K., France, Switzerland, Italy, Spain, Netherlands, Russia, Belgium, Turkey, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, UAE, Saudi Arabia, Israel, Egypt and Rest of Middle East and Africa.

• All country based analysis of electronic clinical outcome assessment (eCOA) market is further analyzed based on further segmentation. By product the market is segmented into on-premise solutions, cloud based solutions and web based solutions. By approach the market is segmented into clinician reported outcome assessment (CLINRO), patient reported outcome assessment (PRO); observer reported outcome assessment (OBSRO) and performance outcome assessment (PERFO). By end user the market is segmented into   commercial service providers, hospitals and transplant centers, research laboratories and academic institutions. By platform the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, medical device manufacturers, hospitals and clinical laboratories, consulting service companies, research and academia and others.

To know more about the study https://www.databridgemarketresearch.com/reports/global-electronic-clinical-outcome-assessment-ecoa-market

Key Pointers Covered in Electronic Clinical Outcome Assessment (eCOA) Market Industry Trends and Forecast to 2027

• Market Size
• Market Standards and Changes
• Market Trials in Different Regions
• Market Requirements in Different Regions
• Market Shares in Diffent Regions
• Recent Developments for Market Competitors
• Recent Market Value for Different regions
• Sales Data for Market Competitors
• Key Vendors and Disruptors Study
• Supply Chain Competiveness
• Value Chain Analysis

Key Market Competitors Covered in the Report

• Oracle
• Parexel International Corporation
• ERT Clinical
• Bioclinica
• IBM Corporation
• eClinical Solutions LLC
• ArisGlobal
• Signant Health
• Medidata
• Omnicomm Systems, Inc.
• YPrime, LLC
• Clinical Ink
• WIRB-Copernicus Group

Above are the key players covered in the report, to know about more and exhaustive list of electronic clinical outcome assessment (eCOA) companies, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-electronic-clinical-outcome-assessment-ecoa-market

Research Methodology: Global Electronic Clinical Outcome Assessment (eCOA) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

• Demand Side: Healthcare Professionals, Clinical Trial Professionals, Pharmaceutical Companies, Life Science Industry, Biotechnology Companies, and CROs among others.
• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Vendors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

• Global Clinical Trial Imaging Market – Industry Trends and Forecast to 2026
• Global Clinical Trial Management System Market– Industry Trends and Forecast to 2025
• Global Clinical Trials Market– Industry Trends and Forecast to 2025

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/